Modern Radiotherapy as Part of Combined Modality Treatment in Locally Advanced Non-Small Cell Lung Cancer: Present Status and Future Prospects
Author:
Affiliation:
1. a Department of Respiratory Medicine, Lung Oncological Network Ghent (LONG), University Hospital, Ghent, Belgium
2. b Department of Radiation Oncology, Lung Oncological Network Ghent (LONG), University Hospital, Ghent, Belgium
Abstract
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2007-0196
Reference58 articles.
1. Cancer Statistics, 2007;Jemal;CA Cancer J Clin,2007
2. Revisions in the international system for staging lung cancer;Mountain;Chest,1997
3. CT-based definition of thoracic lymph node stations: An atlas from the University of Michigan;Chapet;Int J Radiat Oncol Biol Phys,2005
4. Improvements in cancer staging with PET/CT: Literature-based evidence as of September 2006;Czernin;J Nucl Med,2007
5. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition);Silvestri;Chest,2007
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Concept of Cancer Translational Research - A Review;Journal of Population Therapeutics and Clinical Pharmacology;2023-01-01
2. Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy;Radiation Oncology;2020-10-29
3. Hybrid Arc Could Combine the Benefits of IMRT and VMAT to Deliver a Fast, Conformal, Homogeneous Treatment in Non-Small Cell Lung Cancer without Limitations of Low Dose Bath: A Planning Study;International Journal of Hematology and Oncology;2017-09-30
4. Innate Immune Pathways Associated with Lung Radioprotection by Soy Isoflavones;Frontiers in Oncology;2017-01-23
5. Accelerated hypofractionated three-dimensional conformal radiation therapy (3 Gy/fraction) combined with concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer: preliminary results of an early terminated phase II trial;BMC Cancer;2016-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3